Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Nephrologists (US)(?)

Council Members in this Study Group: 525

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Steven Fishbane, MD, Chief of Nephrology, Medical Director, Winthrop-University Hospital IncSteven Fishbane, MD
Chief of Nephrology, Medical Director
Winthrop-University Hospital Inc

Steven Fishbane, MD, is Professor of Medicine at the State University of New York at Stony Brook School of Medicine. Additionally, Dr. Fishbane serves as Chief of Nephrology, Associate Chairman of the Department of Medicine, and Director of End-Stage Renal Disease Research at Winthrop-University Hospital...

Glenn Chertow, MD
Chief, Division of Nephrology
Stanford University School of Medicine

Glenn Chertow, MD, MPH, is Professor of Medicine and Chief, Division of Nephrology, at Stanford University School of Medicine and Director of Nephrology Services at Stanford Hospital and Clinics. His research interests are focused on epidemiology, health services research, and clinical trials in acute...

Richard Amerling, MD, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INCRichard Amerling, MD
Director of Outpatient Dialysis
BETH ISRAEL MEDICAL CENTER INC

Richard Amerling, MD, is Director of Outpatient Dialysis and Continuous Renal Replacement Therapy at the Beth Israel Medical Center in New York City, since June 1990. Dr. Amerling has an extensive background in all aspects of consultative nephrology including hypertension, kidney stones, glomerular...

Jack Rubin, MD
Medical Director
Davita Los Angeles Dialysis Center

Jack Rubin, MD, is Medical Director of the Los Angeles Vascular Access Center (LAVAC) in Inglewood, California. LAVAC does out patient procedures to correct problems with vascular accesses in dialysis patients. LAVAC also does out-patient angiograms of the legs and repairs stenoses of femoral arteries...

Jeffrey Silberzweig, MD
Medical Director
The Rogosin Institute Inc

Jeffrey Silberzweig, MD, is Medical Director of The Rogosin Institute's Manhattan Dialysis Center and the New York Presbyterian Hospital's Inpatient Dialysis Unit as well as the Co-Director of The Rogosin Institute Queens Dialysis Center. He is also a faculty member at Cornell University Medical College....

Andrew Krutul, MD
Clinical Associate Professor
Michigan State University

Andrew Krutul, MD, is a Nephrologist at the Renal Associates of western Michigan in Grand Rapids Michigan. He served for years as a Clinical Section Chief of Nephrology at St Mary's Mercy Medical Center and serves as a Clinical Associate Professor at the Michigan State University School of Medicine....

Jeffrey Perlmutter, MD
Partner
Nephrology Associates of Montgomery County

Jeffrey Perlmutter, MD, is a Nephrologist in private practice in Maryland. He has experience in the treatment of all forms of acute and chronic kidney disease including the care of patients with end stage renal disease requiring dialysis or transplantation. He is the Medical Director of a hospital-based...

Edward Littman, MD
Medical Director
Dva Renal Healthcare, Inc.

Edward Littman, MD, is the Medical Director of the Davita Dialysis Clinics in Norwalk, Connecticut. He also serves as a Clinical Associate Professor of Medicine at the Yale University School of Medicine. Dr. Littman’s major area of expertise is in dialysis treatment of chronic kidney disease. He was...

View all Leading Experts in this Study Group

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Reduction of systolic pressure decreases cognitive decline in susceptible individuals. | 07-30-2008
Analysis of: Blood pressure drugs may protect against Alzheimer's | www.washingtonpost.com
Author: GLG Expert Contributor

Over the past 15 years there have been several long-term trials which have provided evidence that reduction of systolic pressure in an elderly population prevents the cognitive decline associated with ageing. The most recent studies have demonstrated the prevention of Alzheimer's-like symptoms. These...

The Dark Side of Fosamax | 07-25-2008
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: Richard Amerling, MD, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INC

Considering the effects of fosamax and other bisphosphonates on bone remodeling, it is not at all surprising to see problems arising with the long term use of these agents.  

Over Suppression of Bone Turnover May Be Harmful | 07-21-2008
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor

Bisphosphonates, including medications like Fosamax, prevents normal bone turnover and metabolism.  Nephrologists had anticipated similar findings as these recent reports as over-suppression of normal bone turnover may be associated with adynamic bone disease and possibly fractures.  The process...

So Much for Health "Insurance" | 07-10-2008
Analysis of: Pricey Drugs Put Squeeze on Doctors | online.wsj.com
Author: Richard Amerling, MD, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INC

It's intresting that nowhere in this article was the topic of true insurance for catastrophic illness brought up.  The problem with our current health insurance market is that for most it is pre-paid care, not insurance against a rare, but catastrophic, event. 

Our Kids on Statins...........Not! | 07-10-2008
Author: Richard Amerling, MD, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INC

With the pipeline for new drugs running dry, it is no surprise that pharmaceutical companies are looking to expand indications for existing products still under patent protection.  What better way to do this than by creating entirely new patient populations out of whole cloth?

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Physician - Division Head
  • Director
  • Medical Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-05T01:45:16.907